Skip to content

Serotonin research published in 2009

Page 2 of 2: studies 21 to 25 of 25, newest first. Back to the serotonin overview

Studies

Association of serotonin transporter gene polymorphism and emotion regulation.

Neuroreport March 1, 2009 Hiroki Murakami, Masahiro Matsunaga, Hideki Ohira

Metacognitive strategies of emotion regulation such as an objective perspective of one's self are known as primary factors in mindfulness intervention. Earlier studies, however, suggest that the effect of mindfulness differs because of the individual variability. In this study, we investigated the influence of the serotonin transporter gene polymorphism during the application of a metacognitive...

Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.

Journal of Pharmacology and Experimental Therapeutics March 1, 2009 Jun-Xu Li, Kenner C Rice, Charles P France 16 citations

Discriminative stimulus effects of the serotonin (5-HT) receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) have been studied in rats and, more recently, in rhesus monkeys. This study examined DOM, 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), and dipropyltryptamine hydrochloride (DPT) alone and in combination with three antagonists, MDL100907...

DOI: 10.1124/jpet.108.145458 (opens in new tab) Full text (opens in new tab) Serotonin receptor 5-HT Receptor Receptor subtype 5-ht2a receptor affinity +15

Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.

Journal of Neurochemistry February 2009 Elena Puerta, Isabel Hervias, Beatriz Goñi-allo et al.

Phosphodiesterase 5 (PDE5) inhibitors are often used in combination with club drugs such as 3,4-methylenedioxymethamphetamine (MDMA or ecstasy). We investigated the consequences of such combination in the serotonergic system of the rat. Oral administration of sildenafil citrate (1.5 or 8 mg/kg) increased brain cGMP levels and protected in a dose-dependent manner against 5-hydroxytryptamine...

Investigating the role of serotonin in visual orientation processing using an 'ecstasy' (MDMA)-based research model.

Neuropsychobiology 2009 Clare Dickson, Raimondo Bruno, John Brown

A growing body of evidence suggests that regular 'ecstasy' (3,4-methylenedioxymethamphetamine) use causes lasting changes to central serotonergic functioning in humans, including in the occipital lobe. Serotonin may play a role in visual orientation processing, mediated in the occipital lobe, via lateral inhibition. The tilt aftereffect is an illusion apparent following adaptation to stimuli...

MDMA Self-Administration in Laboratory Animals: A Summary of the Literature and Proposal for Future Research

Neuropsychobiology 2009 Susan Schenk 71 citations

The prevalence of 3,4-methylenedioxymethamphetamine (MDMA) use has increased globally and the pattern of consumption has changed considerably. Previously, a subculture of MDMA users was fairly restricted to the dance club scene. More recently, use has spread outside of this subculture and now many users consume MDMA frequently and in large amounts and some meet criteria for drug abuse and/or...